Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Select Medical Holdings Corporation Announces Results for Second Quarter Ended June 30, 2010


News provided by

Select Medical Holdings Corporation

Aug 05, 2010, 04:34 ET

Share this article

Share toX

Share this article

Share toX

MECHANICSBURG, Pa., Aug. 5 /PRNewswire-FirstCall/ -- Select Medical Holdings Corporation ("Select") (NYSE: SEM), today announced results for its second quarter ended June 30, 2010.

For the second quarter ended June 30, 2010, net operating revenues increased 3.6% to $579.9 million compared to $559.5 million for the same quarter, prior year.  Income from operations increased 11.0% to $72.6 million compared to $65.4 million for the same quarter, prior year.  Net income attributable to Select increased 23.6% to $24.5 million compared to $19.8 million for the same quarter, prior year.   Net income attributable to Select for the quarter ended June 30, 2009 included a gain on early retirement of debt, net of tax, of $2.0 million.  Additionally, net income before interest, income taxes, depreciation and amortization, gain on early retirement of debt, stock compensation expense and other income ("Adjusted EBITDA") for the second quarter increased 7.2% to $89.6 million compared to $83.6 million for the same quarter, prior year.  A reconciliation of net income to Adjusted EBITDA is attached to this release.  Income per common share for the second quarter ended June 30, 2010 was $0.15 on a fully diluted basis and weighted average diluted shares outstanding were 159,975,000.  On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000,000 shares of common stock.  On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603,000 shares of common stock.  Upon completion of the initial public offering, Select's participating preferred stock converted into a total of 64,277,000 common shares.

Select's income per common share for the quarter ended June 30, 2009 was $0.19, which included a non-recurring gain related to the early retirement of debt.  Excluding this item, on an adjusted basis income available to common stockholders was $0.16 per diluted share for the quarter ended June 30, 2009.  A reconciliation of net income per share to adjusted net income per share is attached to this release.

For the six months ended June 30, 2010, net operating revenues increased 3.9% to $1,164.7 million compared to $1,120.7 million for the same period, prior year. Income from operations increased 9.2% to $145.2 million compared to $133.0 million for the same period, prior year. Net income attributable to Select increased 8.7% to $48.7 million compared to $44.8 million for the same period, prior year.  Net income attributable to Select for the six months ended June 30, 2009 includes a gain on early retirement of debt, net of tax, of $8.9 million.  Additionally, Adjusted EBITDA for the six months ended June 30, 2010 increased 6.6% to $180.5 million compared to $169.3 million for the same period, prior year.  A reconciliation of net income to Adjusted EBITDA is attached to this release.  Income per common share for the six months ended June 30, 2010 was $0.30 on a fully diluted basis and weighted average diluted shares outstanding were 159,984,000.  On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000,000 shares of common stock.  On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603,000 shares of common stock.  Upon completion of the initial public offering, Select's participating preferred stock converted into a total of 64,277,000 common shares.

Select's income per common share for the six months ended June 30, 2009 was $0.47, which included a non-recurring gain related to the early retirement of debt.  Excluding this item, on an adjusted basis income available to common stockholders was $0.34 per diluted share for the six months ended June 30, 2009.  A reconciliation of net income per share to adjusted net income per share is attached to this release.

Specialty Hospitals

At June 30, 2010, Select operated 89 long term acute care hospitals and six acute medical rehabilitation hospitals.  This compares to 87 long term acute care hospitals and five acute medical rehabilitation hospitals operated at June 30, 2009.  For the second quarter of 2010, net operating revenues for all of Select's hospitals increased 4.3% to $403.1 million compared to $386.3 million for the same quarter, prior year. Total patient days for the second quarter of 2010 were 264,898, admissions were 10,616 and net revenue per patient day was $1,474.  This compares to 252,710 days, 10,504 admissions and net revenue per patient day of $1,491 for the same quarter, prior year.  For the hospitals opened or acquired as of  January 1, 2009 and operated by Select throughout both periods, patient days in the second quarter of 2010 were 258,884 and admissions were 10,304, compared to 251,136 days and 10,433 admissions in the same quarter, prior year.  Adjusted EBITDA for the specialty hospital segment increased 3.4% to $73.3 million compared to $71.0 million for the same quarter, prior year.  The Adjusted EBITDA margin for the segment was 18.2% for the second quarter of 2010, compared to 18.4% for the same quarter, prior year.  The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods was 18.5% for the second quarter of 2010, compared to 18.4% for the same quarter, prior year.  

For the six months ended June 30, 2010, net operating revenues for all of Select's hospitals increased 4.5% to $814.8 million compared to $779.6 million for the same period, prior year. Total patient days for the six months ended June 30, 2010 were 532,746, admissions were 21,717 and net revenue per patient day was $1,483. This compares to 508,983 days, 21,309 admissions and net revenue per patient day of $1,494 for the same period, prior year. For the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods, patient days for the six months ended June 30, 2010 were 521,823, and admissions were 21,122, compared to 505,403 days and 21,164 admissions in the same period, prior year. Adjusted EBITDA for the segment for the six months ended June 30, 2010 increased 5.8% to $156.2 million compared to $147.7 million for the same period, prior year. The Adjusted EBITDA margin for the segment for the six months ended June 30, 2010 was 19.2%, compared to 19.0% for the same period, prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2009 and operated by Select throughout both periods was 19.7% for the six months ended June 30, 2010, compared to 19.0% for the same period, prior year.

Outpatient Rehabilitation

At June 30, 2010, Select operated 953 outpatient clinics.  This compares to 948 outpatient clinics at June 30, 2009.  For the second quarter of 2010, net operating revenues for the outpatient rehabilitation segment increased 2.1% to $176.8 million compared to $173.2 million for the same quarter, prior year.  Adjusted EBITDA for the segment for the second quarter increased 2.6% to $26.0 million compared to $25.3 million for the same quarter, prior year.  The Adjusted EBITDA margin for the segment for the quarter was 14.7% compared to 14.6% in the same quarter, prior year.  Patient visits for the quarter were 1,172,212 compared to 1,163,341 for the same quarter, prior year.   Net revenue per visit was $101 in both quarters.  

For the six months ended June 30, 2010, net operating revenues were $349.9 million compared to $341.0 million for the same period, prior year. Adjusted EBITDA for the six months ended June 30, 2010 decreased 0.2% to $46.5 million compared to $46.6 million for the same period, prior year. The Adjusted EBITDA margin for the six months ended June 30, 2010 was 13.3% compared to 13.7% in the same period, prior year. Patient visits for the six months ended June 30, 2010 were 2,298,170 compared to 2,259,637 for the same period, prior year. Net revenue per visit was $101 for the six months ended June 30, 2010 compared to $102 for the same period, prior year.

Agreement to Purchase Regency Hospital Company, L.L.C.

On June 18, 2010, the Company entered into an agreement to acquire all the issued and outstanding equity securities of Regency Hospital Company, L.L.C. ("Regency") an operator of long-term acute care hospitals, for approximately $210 million, including certain assumed liabilities.  The purchase price is subject to adjustment based on Regency's net working capital on the closing date.  

Regency operates a network of 23 long-term acute care hospitals, located in 9 states.  The transaction, which is expected to close in the third quarter of 2010, is subject to a number of closing conditions, including clearance under the Hart-Scott-Rodino antitrust Improvements Act of 1976, as amended, and receipt of certain healthcare regulatory approvals.

Business Outlook

The Company intends to revise its 2010 business outlook upon the closing of the Regency Transaction.  

Conference Call

The Company will host a conference call regarding its second quarter results and its business outlook on Friday, August 6, 2010, at 9:00am EDT. The domestic dial in number for the call is 1-866-788-0541. The international dial in number is 1-857-350-1679. The passcode for the call is 10011638. The conference call will be webcast simultaneously and can be accessed at Select Medical Holdings Corporation's website http://www.selectmedicalholdings.com.

For those unable to participate in the conference call, a replay will be available until 11:59pm EDT, Friday, August 13, 2010. The replay number is 1-888-286-8010 (domestic) or 1-617-801-6888 (international). The passcode for the replay will be 70263211. The replay can also be accessed at Select Medical Holdings Corporation's website, http://www.selectmedicalholdings.com.

Select Medical Holdings Corporation is a leading operator of specialty hospitals in the United States.  As of June 30, 2010, Select operated 89 long term acute care hospitals and 6 acute medical rehabilitation hospitals in 25 states.  Select is also a leading operator of outpatient rehabilitation clinics in the United States, with approximately 953 locations in 36 states and the District of Columbia.  Select also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites.  Information about Select is available at http://www.selectmedicalholdings.com/

Certain statements contained herein that are not descriptions of historical facts are "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995).  Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements due to factors including the following:

  • additional changes in government reimbursement for our services, including changes that will result from the expiration of the moratorium for long term acute care hospitals established by the SCHIP Extension Act of 2007, the American Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act may result in a reduction in net operating revenues, an increase in costs and a reduction in profitability;
  • the failure of our specialty hospitals to maintain their Medicare certifications as such may cause our net operating revenues and profitability to decline;
  • the failure of our facilities operated as "hospitals within hospitals" or HIHs, to qualify as hospitals separate from their host hospitals may cause our net operating revenues and profitability to decline;
  • a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;
  • future acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;
  • private third-party payors for our services may undertake future cost containment initiatives that limit our future net operating revenues and profitability;
  • the failure to maintain established relationships with the physicians in the areas we serve could reduce our net operating revenues and profitability;
  • shortages in qualified nurses or therapists could increase our operating costs significantly;
  • competition may limit our ability to grow and result in a decrease in our net operating revenues and profitability;
  • the loss of key members of our management team could significantly disrupt our operations;
  • the effect of claims asserted against us or lack of adequate available insurance could subject us to substantial uninsured liabilities;
  • other factors discussed from time to time in our filings with the Securities and Exchange Commission, including factors under the heading "Risk Factors" in our annual report on Form 10-K.

Investor inquiries:


Joel T. Veit

Vice President and Treasurer

717-972-1100

[email protected]

I.   Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

(unaudited)

For the Three Months Ended June 30, 2009 and 2010








2009


2010


%
Change

Net operating revenues

$      559,535


$    579,877


3.6%







Costs and expenses:






Cost of services

453,011


470,044


3.8%

General and administrative

12,885


9,802


(23.9)%

Bad debt expense

10,312


10,845


5.2%

Depreciation and amortization

17,939


16,610


(7.4)%







Income from operations

65,388


72,576


11.0%







Gain on early retirement of debt

3,562


-


N/M

Other income

-


182


N/M

Interest income

28


-


N/M

Interest expense

(33,658)


(29,279)


(13.0)%







Income from operations before income taxes

35,320


43,479


23.1%







Income tax expense

15,137


17,306


14.3%







Net income

20,183


26,173


29.7%







Less:  Net income attributable to non-controlling interests

391


1,711


337.6%







Net income attributable to Select Medical Holdings Corporation

19,792


24,462


23.6%







Less: Preferred dividends

6,508


-


N/M







Net income available to common stockholders and participating securities

$        13,284


$      24,462


84.1%







Income per common share:






    Basic

$0.20


$0.15



    Diluted

$0.19


$0.15









Weighted average shares outstanding (1):






    Basic

60,632


159,709



    Diluted

61,114


159,975









N/M = Not Meaningful












(1) On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000 shares of
common stock.  On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603  
shares of common stock.  Upon completion of the initial public offering, Select's participating preferred stock converted
into a total of 64,277 common shares.

II.   Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

(unaudited)

For the Six Months Ended June 30, 2009 and 2010










2009


2010


%
Change

Net operating revenues


$   1,120,707


$ 1,164,690


3.9%








Costs and expenses:







Cost of services


904,405


942,421


4.2%

General and administrative


25,660


22,591


(12.0)%

Bad debt expense


21,958


20,132


(8.3)%

Depreciation and amortization


35,670


34,321


(3.8)%








Income from operations


133,014


145,225


9.2%








Gain on early retirement of debt


          15,316


                  -


N/M

Other income


                    -


316


N/M

Interest income


                 80


                  -


N/M

Interest expense


(68,330)


(59,321)


(13.2)%








Income from operations before income taxes


80,080


86,220


7.7%








Income tax expense


33,880


34,415


1.6%








Net income


46,200


51,805


12.1%








Less:  Net income attributable to non-controlling interests


1,412


3,117


120.8%








Net income attributable to Select Medical Holdings Corporation


44,788


48,688


8.7%








Less: Preferred dividends


12,870


                  -


N/M








Net income available to common stockholders and participating securities

$        31,918


$      48,688


52.5%








Income per common share:







    Basic


$0.47


$0.30



    Diluted


$0.47


$0.30










Weighted average shares outstanding (1):







    Basic


60,509


159,686



    Diluted


60,991


159,984










N/M = Not Meaningful














(1) On September 30, 2009, Select completed an initial public offering that resulted in the issuance of 30,000 shares of
common stock.  On October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,603
shares common stock.  Upon completion of the initial public offering, Select's participating preferred stock converted  
into a total of 64,277 common shares.








III. Condensed Consolidated Balance Sheets

(In thousands)

(unaudited)








December 31,


June 30,



2009


2010

ASSETS










Cash


$         83,680


$       128,753






Accounts receivable, net


307,079


338,320






Current deferred tax asset


48,535


40,808






Prepaid income taxes


11,179


6,841






Other current assets


24,240


24,730






Total Current Assets


474,713


539,452






Property and equipment, net


466,131


459,567






Goodwill


1,548,269


1,548,269






Other identifiable intangibles


65,297


63,468






Assets held for sale


11,342


11,342






Other assets


36,481


38,025






Total Assets


$    2,602,233


$    2,660,123






LIABILITIES AND EQUITY










Payables and accruals


$       299,796


$       296,972






Current portion of long-term debt


4,145


102,410






Total Current Liabilities


303,941


399,382






Long-term debt, net of current portion


1,401,426


1,305,069






Non-current deferred tax liability


66,768


66,604






Other non-current liabilities


60,543


61,712






Total equity


769,555


827,356






Total Liabilities and Equity

$    2,602,233


$    2,660,123
















IV.   Condensed Consolidated Statements of Cash Flows

(In thousands)

(unaudited)

For the Six Months Ended June 30, 2009 and 2010



2009


2010

Operating activities





Net income


$        46,200


$         51,805

Adjustments to reconcile net income to net cash





   provided by operating activities:





       Depreciation and amortization


          35,670


           34,321

       Provision for bad debts


          21,958


           20,132

       Gain on early retirement of debt


         (15,316)


                    -

       Loss from disposal of assets


               117


                660

  Non-cash gain from interest rate swaps


                    -


              (316)

       Non-cash stock compensation expense


               594


                945

       Amortization of debt discount


               815


                918

       Changes in operating assets and liabilities, net of





           effects from acquisition of businesses:





               Accounts receivable


         (49,155)


         (51,373)

               Other current assets


              (667)


              (495)

               Other assets


            4,242


           (1,140)

               Accounts payable


           (3,693)


           (8,796)

               Due to third-party payors


              (216)


                587

               Accrued expenses and deferred income taxes


          16,686


           11,471

Net cash provided by operating activities


          57,235


           58,719






Investing activities





Purchases of property and equipment


         (20,981)


         (26,454)

Proceeds from sale of property


            1,341


                    -

Net cash used in investing activities


         (19,640)


         (26,454)






Financing activities





Borrowings on revolving credit facility


        138,000


                    -

Payments on revolving credit facility


       (173,000)


                    -

Payment on credit facility term loan


           (3,400)


                    -

Repurchase of 7 5/8% senior subordinated notes


         (30,114)


                    -

Borrowings of other debt


            5,184


             5,015

Principal payments on seller and other debt


           (3,891)


           (4,442)

Repurchase of common and preferred stock


                (80)


                    -

Proceeds from issuance of common stock


                 24


                125

Payment of initial public offering costs


              (417)


                    -

Proceeds from (repayment of) bank overdrafts


           (4,658)


           14,201

Distributions to non-controlling interests


           (1,814)


           (2,091)

Net cash provided by (used in) financing activities


         (74,166)


           12,808






Net increase (decrease) in cash and cash equivalents


         (36,571)


           45,073






Cash and cash equivalents at beginning of period


          64,260


           83,680

Cash and cash equivalents at end of period


$        27,689


$       128,753






Supplemental Cash Flow Information





Cash paid for interest


$        64,710


$         55,928

Cash paid for taxes


$        11,090


$         24,664

V.  Key Statistics

(unaudited)

For the Three Months Ended June 30, 2009 and 2010







%



2009


2010


Change








Specialty Hospitals (a)














Number of hospitals - end of period


92


95


3.3%








Net operating revenues   (,000)


$     386,331


$     403,079


4.3%








Number of patient days


252,710


264,898


4.8%








Number of admissions


10,504


10,616


1.1%








Net revenue per patient day (b)


$         1,491


$         1,474


(1.1)%








Adjusted EBITDA   (,000)


$       70,960


$       73,344


3.4%








Adjusted EBITDA margin – all hospitals


18.4%


18.2%


(1.1)%

Adjusted EBITDA margin – same store hospitals (c)


18.4%


18.5%


0.5%








Outpatient Rehabilitation














Number of clinics - end of period


948


953


0.5%








Net operating revenues   (,000)


$     173,190


$     176,785


2.1%








Number of visits


1,163,341


1,172,212


0.8%








Revenue per visit (d)


$            101


$            101


0.0%








Adjusted EBITDA  (,000)


$       25,294


$       25,956


2.6%








Adjusted EBITDA margin


14.6%


14.7%


0.7%








(a)  Specialty hospitals consist of long term acute care hospitals and acute medical rehabilitation
hospitals.

(b)  Net revenue per patient day is calculated by dividing specialty hospital direct patient service
revenue by the total number of patient days.

(c)  Adjusted EBITDA margin - same store hospitals represents the Adjusted EBITDA margin for
those hospitals opened or acquired before January 1, 2009 and operated throughout both periods.

(d)  Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total
number of visits.  For purposes of this computation, outpatient rehabilitation clinic revenue does not
include managed clinics or contract services revenue.

VI.  Key Statistics

(unaudited)

For the Six Months Ended June 30, 2009 and 2010







%



2009


2010


Change








Specialty Hospitals (a)














Number of hospitals - end of period


                      92


                      95


3.3%








Net operating revenues   (,000)


$           779,563


$           814,764


4.5%








Number of patient days


             508,983


             532,746


4.7%








Number of admissions


               21,309


               21,717


1.9%








Net revenue per patient day (b)


$               1,494


$               1,483


(0.7)%








Adjusted EBITDA   (,000)


$           147,741


$           156,241


5.8%








Adjusted EBITDA margin – all hospitals


19.0%


19.2%


1.1%

Adjusted EBITDA margin – same store hospitals (c)


19.0%


19.7%


3.7%








Outpatient Rehabilitation














Number of clinics - end of period


                    948


                    953


0.5%








Net operating revenues   (,000)


$           341,009


$           349,850


2.6%








Number of visits


          2,259,637


          2,298,170


1.7%








Revenue per visit (d)


$                  102


$                  101


(1.0)%








Adjusted EBITDA  (,000)


$             46,578


$             46,474


(0.2)%








Adjusted EBITDA margin


13.7%


13.3%


(2.9)%








(a)  Specialty hospitals consist of long term acute care hospitals and acute medical rehabilitation hospitals.

(b)  Net revenue per patient day is calculated by dividing specialty hospital direct patient service revenue by the total
number of patient days.

(c)  Adjusted EBITDA margin - same store hospitals represents the Adjusted EBITDA margin for those hospitals
opened or acquired before January 1, 2009 and operated throughout both periods.

(d)  Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of
visits.  For purposes of this computation, outpatient rehabilitation clinic revenue does not include managed clinics or
contract services revenue.

VII.   Net Income to Adjusted EBITDA Reconciliation

(In thousands)

(unaudited)

For the Three and Six Months Ended June 30, 2009 and 2010

The following table reconciles net income to Adjusted EBITDA for Select.  Adjusted EBITDA is used by Select to report its segment performance.  Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, stock compensation expense, other income and gain on early retirement of debt.  We believe that the presentation of Adjusted EBITDA is important to investors because Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating units.

Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles.  Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance.  Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.  Because Adjusted EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.







Three Months Ended June 30,


Six Months Ended June 30,


2009

2010


2009

2010

Net income

$               20,183

$               26,173


$               46,200

$               51,805

Income tax expense

15,137

17,306


33,880

34,415

Other income

-

(182)


-

(316)

Interest expense, net

33,630

29,279


68,250

59,321

Gain on early retirement of debt

(3,562)

-


(15,316)

-

Stock compensation expense






Included in general and administrative

241

111


483

291

Included in cost of services

58

326


111

654

Depreciation and amortization

17,939

16,610


35,670

34,321

Adjusted EBITDA

$               83,626

$               89,623


$             169,278

$             180,491







Specialty hospitals

$               70,960

$               73,344


$             147,741

$             156,241

Outpatient rehabilitation

25,294

25,956


46,578

46,474

Other (1)

(12,628)

(9,677)


(25,041)

(22,224)

Adjusted EBITDA

$               83,626

$               89,623


$             169,278

$             180,491







(1)  Other primarily includes general and administrative costs.

The following tables reconcile specialty hospital same store information.




Three Months Ended



June 30, 2009


June 30, 2010

Specialty hospitals net operating revenue


$                   386,331


$                   403,079

Less:   Specialty hospitals in development, opened, acquired or closed after 1/1/09

                         2,550


                       10,748

Specialty hospitals same store net operating revenue


$                   383,781


$                   392,331






Specialty hospitals Adjusted EBITDA


$                     70,960


$                     73,344

Less:   Specialty hospitals in development, opened, acquired or closed after 1/1/09

                            338


                            582

Specialty hospitals same store Adjusted EBITDA


$                     70,622


$                     72,762






All specialty hospitals Adjusted EBITDA margin


18.4%


18.2%

Specialty hospitals same store Adjusted EBITDA margin


18.4%


18.5%








Six Months Ended



June 30, 2009


June 30, 2010

Specialty hospitals net operating revenue


$                   779,563


$                   814,764

Less:   Specialty hospitals in development, opened, acquired or closed after 1/1/09

                         5,572


                       19,575

Specialty hospitals same store net operating revenue


$                   773,991


$                   795,189






Specialty hospitals Adjusted EBITDA


$                   147,741


$                   156,241

Less:   Specialty hospitals in development, opened, acquired or closed after 1/1/09

                            392


                          (490)

Specialty hospitals same store Adjusted EBITDA


$                   147,349


$                   156,731






All specialty hospitals Adjusted EBITDA margin


19.0%


19.2%

Specialty hospitals same store Adjusted EBITDA margin


19.0%


19.7%











VIII.   Reconciliation of Net Income Per Share to Adjusted Net Income Per Share

(In thousands, except  per share amounts)

(unaudited)

For the Three Months Ended June 30, 2009 and 2010



2009

Per Share (a)


2010

Per Share (a)

Net income

$        20,183

$            0.33


$        26,173

$            0.16

Net income attributable to non-controlling interests

391

0.01


1,711

0.01

Net income attributable to Select Medical Holdings Corporation

19,792

0.32


24,462

0.15

Less:  Preferred dividends

6,508

0.10


-

0.00

Net income available to common stockholders and participating securities

13,284

0.22


24,462

0.15







Gain on early retirement of debt

(3,562)

(0.06)


-

-

Estimated income tax expense (b)

1,502

0.02


-

-


11,224

0.18


24,462

0.15

Allocation to participating securities:






Less:  Earnings allocated to preferred stockholders

1,095

0.02


-

0.00

Less:  Earnings allocated to unvested restricted stockholders

136

0.00


46

0.00







Adjusted net income available to common stockholders

$          9,993

$            0.16


$        24,416

$            0.15

Adjustment for dilution


0.00



0.00

Adjusted net income available to common stockholders - diluted shares


$            0.16



$            0.15







Weighted average common shares outstanding:






Basic


60,632



159,709

Diluted


61,114



159,975







(a)  Per share amounts for each period presented are based on basic weighted average common shares outstanding for all amounts
except adjusted net income available to common stockholders - diluted shares, which is based on diluted shares outstanding.

(b) Represents the tax expense on the adjustments to net income.    

IX.   Reconciliation of Net Income Per Share to Adjusted Net Income Per Share

(In thousands, except  per share amounts)

(unaudited)

For the Six Months Ended June 30, 2009 and 2010








2009

Per Share (a)


2010

Per Share (a)

Net income

$        46,200

$            0.76


$        51,805

$            0.32

Net income attributable to non-controlling interests

1,412

0.02


3,117

0.02

Net income attributable to Select Medical Holdings Corporation

44,788

0.74


48,688

0.30

Less:  Preferred dividends

12,870

0.21


-

0.00

Net income available to common stockholders and participating securities

31,918

0.53


48,688

0.30







Gain on early retirement of debt

(15,316)

(0.25)


-

-

Estimated income tax expense (b)

6,457

0.10


-

-


23,059

0.38


48,688

0.30

Allocation to participating securities:






Less:  Earnings allocated to preferred stockholders

2,250

0.04


-

0.00

Less:  Earnings allocated to unvested restricted stockholders

320

0.00


97

0.00







Adjusted net income available to common stockholders

$        20,489

$            0.34


$        48,591

$            0.30

Adjustment for dilution


0.00



0.00

Adjusted net income available to common stockholders - diluted shares


$            0.34



$            0.30







Weighted average common shares outstanding:






Basic


60,509



159,686

Diluted


60,991



159,984







(a)  Per share amounts for each period presented are based on basic weighted average common shares outstanding for all amounts
except adjusted net income available to common stockholders - diluted shares, which is based on diluted shares outstanding.

(b) Represents the tax expense on the adjustments to net income.      


SOURCE Select Medical Holdings Corporation

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Select Medical Holdings Corporation Acknowledges Executive Chairman's Take-Private Proposal

Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) has received a non-binding indication of interest from...

Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2025 and Cash Dividend

Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Earnings

Earnings

Earnings

Earnings

Conference Call Announcements

Conference Call Announcements

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.